Pneumococcal Vaccine: An Emerging Consensus

Editorials1 May 1988Pneumococcal Vaccine: An Emerging ConsensusF. MARC LAFORCE, M.D., THEODORE C. EICKHOFF, M.D.F. MARC LAFORCE, M.D.Search for more papers by this author, THEODORE C. EICKHOFF, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-108-5-757 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptA refreshing and long overdue emphasis on disease prevention is percolating through much of the practice of medicine in the United States. As part of this initiative, the proper use of vaccines in adult populations has received new emphasis and a variety of authoritative panels have emphasized the importance of pneumococcal vaccine in U.S. adults (1-3). Adults with chronic cardiac or pulmonary diseases and those with illnesses associated with an increased risk for pneumococcal disease or its complications have been targeted for immunization as well as the healthy elderly. Despite these urgings, coverage rates with pneumococcal vaccine are low (4),...References1. . Update: Pneumococcal polysaccharide vaccine usage—United States. MMWR. 1984;33:273-81. MedlineGoogle Scholar2. . Pneumococcal vaccine. Ann Intern Med. 1986; 104:118-20. LinkGoogle Scholar3. LAFORCE F. Immunizations, immunoprophylaxis, and chemoprophylaxis to prevent selected infections. JAMA. 1987;257:2464-70. CrossrefMedlineGoogle Scholar4. POLISSMITHSAINTERBRENNEMANKASLOW MJDMR. Prospects for an emergency department-based adult immunization program. Arch Intern Med. 1987;147:1999-2001. CrossrefMedlineGoogle Scholar5. AUSTRIAN R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis. 1981;3(Suppl):S1-S17. CrossrefMedlineGoogle Scholar6. RILEYLEHMANNALPERSDEC MARSHALLGRATTENSMITH IDMTHD. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children. Lancet. 1986;2:877-81. CrossrefMedlineGoogle Scholar7. LAFORCEEICKHOFF FT. Pneumococcal vaccine: the evidence mounts. Ann Intern Med. 1986;104:110-12. LinkGoogle Scholar8. SIMBERKOFFCROSSAL-IBRAHIM MAM. Efficacy of pneumococcal vaccine in high-risk patients. N Engl J Med. 1986;315:1316-27. CrossrefGoogle Scholar9. FORRESTERJAHNIGENLAFORCE HDF. Inefficacy of pneumococcal vaccine in a high-risk population. Am J Med. 1987;83:425-30. CrossrefMedlineGoogle Scholar10. SHAPIROCLEMENS EJ. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infection. Ann Intern Med. 1984;101:325-30. LinkGoogle Scholar11. SIMSSTEINMANNMCCONVILLEKINGZWICKSCHWARTZ RWJLWJ. The clinical effectiveness of the pneumococcal vaccine in the elderly. Ann Intern Med. 1988;108:653-7. LinkGoogle Scholar12. SHAPIROAUSTRIANADAIRCLEMENS ERRJ. The protective efficacy of pneumococcal vaccine [Abstract]. Clin Res. 1988;36:470 A. Google Scholar13. GAILLATZMIROUMALLARET JDM. Essai clinique due vaccin antipneumococcique chez des personnes agees vivant en institution. Rev Epidemol Sante Publique. 1985;33:437-44. MedlineGoogle Scholar14. ESKOLAPELTOLATAKALA JHA. Efficacy of Haemophilus influenzae Type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med. 1987;317:717-22. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited BySynthesis and in vitro chemical and enzymatic stability of glycosyl 3′-azido-3′-deoxythymidine derivatives as potential anti-HIV agentsInterleukin-10 Enhances Immune Responses to Pneumococcal Polysaccharides and Sheep Erythrocytes in Young and Aged MiceCharacteristics of patients with community‐acquired pneumococcal pneumoniaDas Immunsystem und Infektionen im AlterAntibodies to pneumococcal polysaccharides in human milk: lack of relationship to colonization and acute otitis mediaApproach to Fever and Infection in the Nursing HomeEvidence of recombination and an antigenically diverse immunoglobulin A1 protease among strains of Streptococcus pneumoniaePractical Use of Vaccines to Prevent Infection with Influenza Virus and Streptococcus pneumoniaeConventional and New Generation Combined VaccinesThymus-Independent AntigensReversal of age-associated decline in immune response to Pnu-imune vaccine by supplementation with the steroid hormone dehydroepiandrosteroneInfluenza and pneumococcal vaccination of HIV-infected patients: A policy analysisImmune responses of systemic and mucosal lymphoid organs to Pnu-Imune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvantMedical care of the elderly in the nursing homeComparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniaePneumococcal Vaccine — Past, Present, and FutureORAL ENTERIC VACCINES—CLINICAL TRIALSAPIC guideline for infection prevention and control in the long-term care facilityAn Outbreak of Pneumococcal Pneumonia in Two Men's SheltersDraft guideline for infection prevention and control in the long term care facilityPneumococcal Vaccination: Work to Date and Future ProspectsPneumococcus and influenzaQuantitation of IgG antibody to Streptococcus pneumoniae vaccine by ELISA and FAST-ELISA using tyraminated antigenAdult ImmunizationBacterial pneumonias in the elderlyVaccination against pneumococcal infection. 1 May 1988Volume 108, Issue 5Page: 757-759KeywordsAdultsElderlyHeart diseasesPopulation statisticsPulmonary diseasesVaccines Issue Published: 1 May 1988 PDF DownloadLoading ...